A Critical Review of CAR-T Therapies for Glioblastoma: What’s Wrong with the Current Attempts?

Today, CAR-T therapy has been widely acknowledged as a “gold standard” treatment for certain hematologic diseases. There is a relatively small but enhancing body of clinical trials studying the effectiveness of CAR-T in treating glioblastoma, known as the most common and aggressive brain tumor in ad...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Sergei V. Belokon, Valeriya A. Kukarskaya, Ilya D. Klabukov, Victoria A. Shestakova, Sergei A. Ivanov, Petr V. Shegay, Andrei D. Kaprin, Denis S. Baranovskii
Format:	Artigo
Jezik:	Inglês
Izdano:	Wolters Kluwer Medknow Publications 2025-04-01
Serija:	Hematology/Oncology and Stem Cell Therapy
Teme:	immunotherapy glioblastoma high-grade glioma mri evaluation car-t
Online dostop:	https://journals.lww.com/10.4103/hemoncstem.HEMONCSTEM-D-24-00040
Oznake:	Označite Brez oznak, prvi označite!